Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 484 entries
Sorted by: Best Match Show Resources per page
Action plans and coping strategies in elderly COPD patients influence the result of pulmonary rehabilitation: an observational study.

European journal of physical and rehabilitation medicine

Russo P, Prinzi G, Kisialiou A, Cardaci V, Stirpe E, Conti V, Fini M, Bonassi S.
PMID: 28417609
Eur J Phys Rehabil Med. 2017 Apr 14; doi: 10.23736/S1973-9087.17.04501-4. Epub 2017 Apr 14.

BACKGROUND: COPD management needs a comprehensive assessment of clinical features (symptoms severity, co-morbidities) together with life-style, behavioural, socio-economic and multi-omics parameters. Among the other issues, psycho-cognitive assessment plays a critical role. Coping strategies are used to manage psychological stress.AIM:...

Cite
Russo P, Prinzi G, Kisialiou A, et al. Action plans and coping strategies in elderly COPD patients influence the result of pulmonary rehabilitation: an observational study. Eur J Phys Rehabil Med. 2017;doi: 10.23736/S1973-9087.17.04501-4.
Russo, P., Prinzi, G., Kisialiou, A., Cardaci, V., Stirpe, E., Conti, V., Fini, M., & Bonassi, S. (2017). Action plans and coping strategies in elderly COPD patients influence the result of pulmonary rehabilitation: an observational study. European journal of physical and rehabilitation medicine, . https://doi.org/10.23736/S1973-9087.17.04501-4
Russo, Patrizia, et al. "Action plans and coping strategies in elderly COPD patients influence the result of pulmonary rehabilitation: an observational study." European journal of physical and rehabilitation medicine vol. (2017). doi: https://doi.org/10.23736/S1973-9087.17.04501-4
Russo P, Prinzi G, Kisialiou A, Cardaci V, Stirpe E, Conti V, Fini M, Bonassi S. Action plans and coping strategies in elderly COPD patients influence the result of pulmonary rehabilitation: an observational study. Eur J Phys Rehabil Med. 2017 Apr 14; doi: 10.23736/S1973-9087.17.04501-4. Epub 2017 Apr 14. PMID: 28417609.
Copy Download .nbib Format: NLM
Application of (119)Sn CPMG MAS NMR for Fast Characterization of Sn Sites in Zeolites with Natural (119)Sn Isotope Abundance.

The journal of physical chemistry letters

Kolyagin YG, Yakimov AV, Tolborg S, Vennestrøm PN, Ivanova II.
PMID: 26978430
J Phys Chem Lett. 2016 Apr 07;7(7):1249-53. doi: 10.1021/acs.jpclett.6b00249. Epub 2016 Mar 18.

(119)Sn CPMG MAS NMR is demonstrated to be a fast and efficient method for characterization of Sn-sites in Sn-containing zeolites. Tuning of the CPMG echo-train sequence decreases the experimental time by a factor of 5-40 in the case of...

Cite
Kolyagin YG, Yakimov AV, Tolborg S, et al. Application of (119)Sn CPMG MAS NMR for Fast Characterization of Sn Sites in Zeolites with Natural (119)Sn Isotope Abundance. J Phys Chem Lett. 2016;7(7):1249-53doi: 10.1021/acs.jpclett.6b00249.
Kolyagin, Y. G., Yakimov, A. V., Tolborg, S., Vennestrøm, P. N., & Ivanova, I. I. (2016). Application of (119)Sn CPMG MAS NMR for Fast Characterization of Sn Sites in Zeolites with Natural (119)Sn Isotope Abundance. The journal of physical chemistry letters, 7(7), 1249-53. https://doi.org/10.1021/acs.jpclett.6b00249
Kolyagin, Yury G, et al. "Application of (119)Sn CPMG MAS NMR for Fast Characterization of Sn Sites in Zeolites with Natural (119)Sn Isotope Abundance." The journal of physical chemistry letters vol. 7,7 (2016): 1249-53. doi: https://doi.org/10.1021/acs.jpclett.6b00249
Kolyagin YG, Yakimov AV, Tolborg S, Vennestrøm PN, Ivanova II. Application of (119)Sn CPMG MAS NMR for Fast Characterization of Sn Sites in Zeolites with Natural (119)Sn Isotope Abundance. J Phys Chem Lett. 2016 Apr 07;7(7):1249-53. doi: 10.1021/acs.jpclett.6b00249. Epub 2016 Mar 18. PMID: 26978430.
Copy Download .nbib Format: NLM
Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases.

Therapeutic advances in chronic disease

D'Ambrosio D, Freedman MS, Prinz J.
PMID: 26770667
Ther Adv Chronic Dis. 2016 Jan;7(1):18-33. doi: 10.1177/2040622315617354.

The first oral treatment for relapsing multiple sclerosis, the nonselective sphingosine-1-phosphate receptor (S1PR) modulator fingolimod, led to identification of a pivotal role of sphingosine-1-phosphate and one of its five known receptors, S1P1R, in regulation of lymphocyte trafficking in multiple...

Cite
D'Ambrosio D, Freedman MS, Prinz J. Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases. Ther Adv Chronic Dis. 2016;7(1):18-33doi: 10.1177/2040622315617354.
D'Ambrosio, D., Freedman, M. S., & Prinz, J. (2016). Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases. Therapeutic advances in chronic disease, 7(1), 18-33. https://doi.org/10.1177/2040622315617354
D'Ambrosio, Daniele, et al. "Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases." Therapeutic advances in chronic disease vol. 7,1 (2016): 18-33. doi: https://doi.org/10.1177/2040622315617354
D'Ambrosio D, Freedman MS, Prinz J. Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases. Ther Adv Chronic Dis. 2016 Jan;7(1):18-33. doi: 10.1177/2040622315617354. PMID: 26770667; PMCID: PMC4707431.
Copy Download .nbib Format: NLM
Active pump-seed-pulse synchronization for OPCPA with sub-2-fs residual timing jitter.

Optics express

Prinz S, Häfner M, Schultze M, Teisset CY, Bessing R, Michel K, Kienberger R, Metzger T.
PMID: 25607054
Opt Express. 2014 Dec 15;22(25):31050-6. doi: 10.1364/OE.22.031050.

Short-pulse-pumped optical parametric chirped pulse amplification (OPCPA) requires a precise temporal overlap of the interacting pulses in the nonlinear crystal to achieve stable performance. We present active synchronization of the ps-pump pulses and the broadband seed pulses used in...

Cite
Prinz S, Häfner M, Schultze M, et al. Active pump-seed-pulse synchronization for OPCPA with sub-2-fs residual timing jitter. Opt Express. 2014;22(25):31050-6doi: 10.1364/OE.22.031050.
Prinz, S., Häfner, M., Schultze, M., Teisset, C. Y., Bessing, R., Michel, K., Kienberger, R., & Metzger, T. (2014). Active pump-seed-pulse synchronization for OPCPA with sub-2-fs residual timing jitter. Optics express, 22(25), 31050-6. https://doi.org/10.1364/OE.22.031050
Prinz, Stephan, et al. "Active pump-seed-pulse synchronization for OPCPA with sub-2-fs residual timing jitter." Optics express vol. 22,25 (2014): 31050-6. doi: https://doi.org/10.1364/OE.22.031050
Prinz S, Häfner M, Schultze M, Teisset CY, Bessing R, Michel K, Kienberger R, Metzger T. Active pump-seed-pulse synchronization for OPCPA with sub-2-fs residual timing jitter. Opt Express. 2014 Dec 15;22(25):31050-6. doi: 10.1364/OE.22.031050. PMID: 25607054.
Copy Download .nbib Format: NLM
Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.

Therapeutic advances in medical oncology

Pusceddu S, Verzoni E, Prinzi N, Mennitto A, Femia D, Grassi P, Concas L, Vernieri C, Lo Russo G, Procopio G.
PMID: 28344663
Ther Adv Med Oncol. 2017 Mar;9(3):183-188. doi: 10.1177/1758834016683905. Epub 2017 Jan 11.

Neuroendocrine tumors (NETs) are a heterogeneous class of diseases characterized by challenging management. Preclinical evidence shows that the PI3K/AKT/mTOR signaling pathway plays a central role in the pathogenesis and progression of NETs. Everolimus is a direct inhibitor of this...

Cite
Pusceddu S, Verzoni E, Prinzi N, et al. Everolimus treatment for neuroendocrine tumors: latest results and clinical potential. Ther Adv Med Oncol. 2017;9(3):183-188doi: 10.1177/1758834016683905.
Pusceddu, S., Verzoni, E., Prinzi, N., Mennitto, A., Femia, D., Grassi, P., Concas, L., Vernieri, C., Lo Russo, G., & Procopio, G. (2017). Everolimus treatment for neuroendocrine tumors: latest results and clinical potential. Therapeutic advances in medical oncology, 9(3), 183-188. https://doi.org/10.1177/1758834016683905
Pusceddu, Sara, et al. "Everolimus treatment for neuroendocrine tumors: latest results and clinical potential." Therapeutic advances in medical oncology vol. 9,3 (2017): 183-188. doi: https://doi.org/10.1177/1758834016683905
Pusceddu S, Verzoni E, Prinzi N, Mennitto A, Femia D, Grassi P, Concas L, Vernieri C, Lo Russo G, Procopio G. Everolimus treatment for neuroendocrine tumors: latest results and clinical potential. Ther Adv Med Oncol. 2017 Mar;9(3):183-188. doi: 10.1177/1758834016683905. Epub 2017 Jan 11. PMID: 28344663; PMCID: PMC5349426.
Copy Download .nbib Format: NLM
Expression differences of programmed death ligand 1 in de-novo and recurrent glioblastoma multiforme.

Oncotarget

Heynckes S, Gaebelein A, Haaker G, Grauvogel J, Franco P, Mader I, Carro MS, Prinz M, Delev D, Schnell O, Heiland DH.
PMID: 29088776
Oncotarget. 2017 Jun 28;8(43):74170-74177. doi: 10.18632/oncotarget.18819. eCollection 2017 Sep 26.

The biology of recurrent glioblastoma multiforme (GBM) is a dynamic process influenced by selection pressure induced by different antitumoural therapies. The poor clinical outcome of tumours in the recurrent stage necessitates the development of effective therapeutic strategies. Checkpoint-inhibition (PD1/PD-L1...

Cite
Heynckes S, Gaebelein A, Haaker G, et al. Expression differences of programmed death ligand 1 in de-novo and recurrent glioblastoma multiforme. Oncotarget. 2017;8(43):74170-74177doi: 10.18632/oncotarget.18819.
Heynckes, S., Gaebelein, A., Haaker, G., Grauvogel, J., Franco, P., Mader, I., Carro, M. S., Prinz, M., Delev, D., Schnell, O., & Heiland, D. H. (2017). Expression differences of programmed death ligand 1 in de-novo and recurrent glioblastoma multiforme. Oncotarget, 8(43), 74170-74177. https://doi.org/10.18632/oncotarget.18819
Heynckes, Sabrina, et al. "Expression differences of programmed death ligand 1 in de-novo and recurrent glioblastoma multiforme." Oncotarget vol. 8,43 (2017): 74170-74177. doi: https://doi.org/10.18632/oncotarget.18819
Heynckes S, Gaebelein A, Haaker G, Grauvogel J, Franco P, Mader I, Carro MS, Prinz M, Delev D, Schnell O, Heiland DH. Expression differences of programmed death ligand 1 in de-novo and recurrent glioblastoma multiforme. Oncotarget. 2017 Jun 28;8(43):74170-74177. doi: 10.18632/oncotarget.18819. eCollection 2017 Sep 26. PMID: 29088776; PMCID: PMC5650331.
Copy Download .nbib Format: NLM
Inadvertent Trypan Blue Staining of Posterior Capsule during Cataract Surgery Associated with "Argentinian Flag" Event.

Case reports in ophthalmological medicine

Prinzi RA, Alapati NM, Gappy SS, Dilly JS.
PMID: 27022495
Case Rep Ophthalmol Med. 2016;2016:9025063. doi: 10.1155/2016/9025063. Epub 2016 Feb 28.

Trypan blue is common in visualizing the anterior capsule during cataract surgery. Inadvertent staining of the posterior capsule during phacoemulsification is a rare complication and there are few reports in the literature. The proposed mechanism of posterior capsule staining...

Cite
Prinzi RA, Alapati NM, Gappy SS, et al. Inadvertent Trypan Blue Staining of Posterior Capsule during Cataract Surgery Associated with "Argentinian Flag" Event. Case Rep Ophthalmol Med. 2016;2016:9025063doi: 10.1155/2016/9025063.
Prinzi, R. A., Alapati, N. M., Gappy, S. S., & Dilly, J. S. (2016). Inadvertent Trypan Blue Staining of Posterior Capsule during Cataract Surgery Associated with "Argentinian Flag" Event. Case reports in ophthalmological medicine, 20169025063. https://doi.org/10.1155/2016/9025063
Prinzi, Robert A, et al. "Inadvertent Trypan Blue Staining of Posterior Capsule during Cataract Surgery Associated with "Argentinian Flag" Event." Case reports in ophthalmological medicine vol. 2016 (2016): 9025063. doi: https://doi.org/10.1155/2016/9025063
Prinzi RA, Alapati NM, Gappy SS, Dilly JS. Inadvertent Trypan Blue Staining of Posterior Capsule during Cataract Surgery Associated with "Argentinian Flag" Event. Case Rep Ophthalmol Med. 2016;2016:9025063. doi: 10.1155/2016/9025063. Epub 2016 Feb 28. PMID: 27022495; PMCID: PMC4789063.
Copy Download .nbib Format: NLM
Pericentral hydroxychloroquine retinopathy in a Caucasian female.

American journal of ophthalmology case reports

Anand N, Prinzi RA, Hoeferlin C, Yan J, Jain N.
PMID: 29577098
Am J Ophthalmol Case Rep. 2018 Jan 13;9:93-95. doi: 10.1016/j.ajoc.2018.01.019. eCollection 2018 Mar.

PURPOSE: To report a rare presentation of the pericentral pattern of hydroxychloroquine (HCQ) retinal toxicity in a Caucasian female.OBSERVATIONS: The patient presented with 20 years of exposure to HCQ, at a daily dose of 5.2mg/kg of actual body weight,...

Cite
Anand N, Prinzi RA, Hoeferlin C, et al. Pericentral hydroxychloroquine retinopathy in a Caucasian female. Am J Ophthalmol Case Rep. 2018;9:93-95doi: 10.1016/j.ajoc.2018.01.019.
Anand, N., Prinzi, R. A., Hoeferlin, C., Yan, J., & Jain, N. (2018). Pericentral hydroxychloroquine retinopathy in a Caucasian female. American journal of ophthalmology case reports, 993-95. https://doi.org/10.1016/j.ajoc.2018.01.019
Anand, Nikhil, et al. "Pericentral hydroxychloroquine retinopathy in a Caucasian female." American journal of ophthalmology case reports vol. 9 (2018): 93-95. doi: https://doi.org/10.1016/j.ajoc.2018.01.019
Anand N, Prinzi RA, Hoeferlin C, Yan J, Jain N. Pericentral hydroxychloroquine retinopathy in a Caucasian female. Am J Ophthalmol Case Rep. 2018 Jan 13;9:93-95. doi: 10.1016/j.ajoc.2018.01.019. eCollection 2018 Mar. PMID: 29577098; PMCID: PMC5861633.
Copy Download .nbib Format: NLM
CEP-stable, sub-6 fs, 300-kHz OPCPA system with more than 15 W of average power.

Optics express

Prinz S, Haefner M, Teisset CY, Bessing R, Michel K, Lee Y, Geng XT, Kim S, Kim DE, Metzger T, Schultze M.
PMID: 25835897
Opt Express. 2015 Jan 26;23(2):1388-94. doi: 10.1364/OE.23.001388.

We report on a CEP-stable OPCPA system reaching multi-GW peak powers at 300 kHz repetition rate. It delivers 15 W of average power, over 50 µJ of compressed pulse energy and a pulse duration below 6 fs. By implementing...

Cite
Prinz S, Haefner M, Teisset CY, et al. CEP-stable, sub-6 fs, 300-kHz OPCPA system with more than 15 W of average power. Opt Express. 2015;23(2):1388-94doi: 10.1364/OE.23.001388.
Prinz, S., Haefner, M., Teisset, C. Y., Bessing, R., Michel, K., Lee, Y., Geng, X. T., Kim, S., Kim, D. E., Metzger, T., & Schultze, M. (2015). CEP-stable, sub-6 fs, 300-kHz OPCPA system with more than 15 W of average power. Optics express, 23(2), 1388-94. https://doi.org/10.1364/OE.23.001388
Prinz, Stephan, et al. "CEP-stable, sub-6 fs, 300-kHz OPCPA system with more than 15 W of average power." Optics express vol. 23,2 (2015): 1388-94. doi: https://doi.org/10.1364/OE.23.001388
Prinz S, Haefner M, Teisset CY, Bessing R, Michel K, Lee Y, Geng XT, Kim S, Kim DE, Metzger T, Schultze M. CEP-stable, sub-6 fs, 300-kHz OPCPA system with more than 15 W of average power. Opt Express. 2015 Jan 26;23(2):1388-94. doi: 10.1364/OE.23.001388. PMID: 25835897.
Copy Download .nbib Format: NLM
Characterization and transferability of microsatellite markers developed for Carpinus betulus (Betulaceae)(1).

Applications in plant sciences

Prinz K, Finkeldey R.
PMID: 26504678
Appl Plant Sci. 2015 Oct 12;3(10). doi: 10.3732/apps.1500053. eCollection 2015 Oct.

PREMISE OF THE STUDY: Carpinus betulus (Betulaceae) is an octoploid, ecologically important, common tree species in European woodlands. We established 11 nuclear microsatellite loci allowing for detailed analyses of genetic diversity and structure.METHODS AND RESULTS: A microsatellite-enriched library was...

Cite
Prinz K, Finkeldey R. Characterization and transferability of microsatellite markers developed for Carpinus betulus (Betulaceae)(1). Appl Plant Sci. 2015;3(10)doi: 10.3732/apps.1500053.
Prinz, K., & Finkeldey, R. (2015). Characterization and transferability of microsatellite markers developed for Carpinus betulus (Betulaceae)(1). Applications in plant sciences, 3(10), . https://doi.org/10.3732/apps.1500053
Prinz, Kathleen, and Finkeldey, Reiner. "Characterization and transferability of microsatellite markers developed for Carpinus betulus (Betulaceae)(1)." Applications in plant sciences vol. 3,10 (2015). doi: https://doi.org/10.3732/apps.1500053
Prinz K, Finkeldey R. Characterization and transferability of microsatellite markers developed for Carpinus betulus (Betulaceae)(1). Appl Plant Sci. 2015 Oct 12;3(10). doi: 10.3732/apps.1500053. eCollection 2015 Oct. PMID: 26504678; PMCID: PMC4610309.
Copy Download .nbib Format: NLM
[S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease].

Zeitschrift fur Gastroenterologie

Fischbach W, Malfertheiner P, Lynen Jansen P, Bolten W, Bornschein J, Buderus S, Glocker E, Hoffmann CJ, Koletzko S, Labenz J, Mayerle J, Miehlke S, Mössner J, Peitz U, Prinz C, Selgrad M, Suerbaum S, Venerito M, Vieth M.
PMID: 27168132
Z Gastroenterol. 2016 Apr;54(4):1. doi: 10.1055/s-0035-1567086. Epub 2016 May 11.

In the line "bismuth-containing quadruple therapy" of Table 7 (p 342), in the column "dosage" incorrectly at the three antibiotics respectively 1-1-1-1. The correct is: 3-3-3-3.

Cite
Fischbach W, Malfertheiner P, Lynen Jansen P, et al. S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit. [S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease]. Z Gastroenterol. 2016;54(4):1doi: 10.1055/s-0035-1567086.
Fischbach, W., Malfertheiner, P., Lynen Jansen, P., Bolten, W., Bornschein, J., Buderus, S., Glocker, E., Hoffmann, C. J., Koletzko, S., Labenz, J., Mayerle, J., Miehlke, S., Mössner, J., Peitz, U., Prinz, C., Selgrad, M., Suerbaum, S., Venerito, M., Vieth, M. (2016). S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit. [S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease]. Zeitschrift fur Gastroenterologie, 54(4), 1. https://doi.org/10.1055/s-0035-1567086
Fischbach, W, et al. "S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit." [S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease]. Zeitschrift fur Gastroenterologie vol. 54,4 (2016): 1. doi: https://doi.org/10.1055/s-0035-1567086
Fischbach W, Malfertheiner P, Lynen Jansen P, Bolten W, Bornschein J, Buderus S, Glocker E, Hoffmann CJ, Koletzko S, Labenz J, Mayerle J, Miehlke S, Mössner J, Peitz U, Prinz C, Selgrad M, Suerbaum S, Venerito M, Vieth M. S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit. [S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease]. Z Gastroenterol. 2016 Apr;54(4):1. doi: 10.1055/s-0035-1567086. Epub 2016 May 11. German. PMID: 27168132.
Copy Download .nbib Format: NLM
Communication: Visible line intensities of the triatomic hydrogen ion from experiment and theory.

The Journal of chemical physics

Petrignani A, Berg MH, Grussie F, Wolf A, Mizus II, Polyansky OL, Tennyson J, Zobov NF, Pavanello M, Adamowicz L.
PMID: 25554125
J Chem Phys. 2014 Dec 28;141(24):241104. doi: 10.1063/1.4904440.

The visible spectrum of H3(+) is studied using high-sensitivity action spectroscopy in a cryogenic radiofrequency multipole trap. Advances are made to measure the weak ro-vibrational transitions from the lowest rotational states of H3(+) up to high excitation energies providing...

Cite
Petrignani A, Berg MH, Grussie F, et al. Communication: Visible line intensities of the triatomic hydrogen ion from experiment and theory. J Chem Phys. 2014;141(24):241104doi: 10.1063/1.4904440.
Petrignani, A., Berg, M. H., Grussie, F., Wolf, A., Mizus, I. I., Polyansky, O. L., Tennyson, J., Zobov, N. F., Pavanello, M., & Adamowicz, L. (2014). Communication: Visible line intensities of the triatomic hydrogen ion from experiment and theory. The Journal of chemical physics, 141(24), 241104. https://doi.org/10.1063/1.4904440
Petrignani, Annemieke, et al. "Communication: Visible line intensities of the triatomic hydrogen ion from experiment and theory." The Journal of chemical physics vol. 141,24 (2014): 241104. doi: https://doi.org/10.1063/1.4904440
Petrignani A, Berg MH, Grussie F, Wolf A, Mizus II, Polyansky OL, Tennyson J, Zobov NF, Pavanello M, Adamowicz L. Communication: Visible line intensities of the triatomic hydrogen ion from experiment and theory. J Chem Phys. 2014 Dec 28;141(24):241104. doi: 10.1063/1.4904440. PMID: 25554125.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 484 entries